APRE

Aprea Therapeutics Inc

Latest period2024 - Q3Total superinvestors21

Top 10 Superinvestors by Shares Owned

This chart shows the top 10 superinvestors based on the number of shares they owned in 2024-Q2 and 2024-Q3. According to the most recent SEC 13F filing, 21 superinvestors own shares of Aprea Therapeutics Inc (APRE), although recent data may remain incomplete due to pending filings.

Quarter-over-Quarter Change (%)

This chart highlights the quarter-over-quarter change (%) in the number of superinvestors holding Aprea Therapeutics Inc (APRE), the total shares they held, and the total reported dollar value. It gives a clear view of whether there is ongoing momentum. The dotted lines at the top and bottom adjust longer bars to keep smaller data points visible for better comparison.

Superinvestors' Activity (%) Over the Last 4 Quarters

This chart shows superinvestors' activity with Aprea Therapeutics Inc (APRE) over the last four quarters, highlighting the percentage of investors who added, increased, decreased, held, or exited their positions, revealing shifts in sentiment over time.

Superinvestors' Past Actions

This chart displays superinvestors' past actions with Aprea Therapeutics Inc (APRE) over the last 10 years (40 quarters), helping to visualize the collective momentum and investment trends over time.

Superinvestors ownership

CurrentNew PositionIncreasedDecreasedExited
SuperinvestorPortfolio %Reported Value
Mark Gottlieb@Altium Capital Management Lp
Recent Activity
Exited
0%
$558.392M
137,197 shares@ 4070.01 avg price
Brian Sopinsky@Susquehanna International Group, Llp
Recent Activity
Exited
0%
$41,184
10,119 shares@ 4.07 avg price
Sherry Coulter@Royal Bank Of Canada
Recent Activity
Exited
0%
$23,000
5,694 shares@ 4.04 avg price
Gregory H. Kozich@Pnc Financial Services Group, Inc.
Recent Activity
Exited
0%
$4,070
1,000 shares@ 4.07 avg price
Patricia Arce@Wells Fargo & Company Mn
Recent Activity
Exited
0%
$1,018
250 shares@ 4.08 avg price
Rodney Ancrum@Aviso Financial Inc.
Recent Activity
Exited
0%
$41
10 shares@ 4.1 avg price